Baylor College of Medicine

Reverse Phase Protein Array Instrumentation & Technology

Reverse phase protein array (RPPA) is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body ...
Seeking Alpha

Theralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U.S.

GOLDEN, Colo., Nov. 28, 2022 /PRNewswire/ -- Theralink Technologies (THER) (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay for breast ...
ascopubs.org

Classification of molecular subtypes of triple-negative breast cancer using reverse phase protein arrays (RPPAs).

Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text ...

Biomednewsbreaks - Aditxt Inc. (NASDAQ: ADTX) Subsidiary Featured In Nature Journal Study On Breast Cancer Biomarkers

Subsidiary Featured In Nature Journal Study On Breast Cancer Biomarkers. Aditxt (NASDAQ: ADTX) announced its precision oncology subsidiary, Ignite Proteomics, was featured in a peer-reviewed study ...
ascopubs.org

Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays

Predicting cancer dependencies from molecular data can help stratify patients and identify novel therapeutic targets. Recently available data on large-scale cancer cell line dependency allow a ...
Baylor College of Medicine

Reverse Phase Protein Array

Antibody-based reverse-phase protein arrays to quantitatively analyze specific protein pathways and their activation states with large sample sets (tissue or cells). Approximately 290+ validated ...